JPRN-UMIN000014481已完成未知
The novel therapeutic cancer peptide vaccine therapy for patients with locally advanced or metastatic pacreatic cancer combined with Gemcitabine as the first line therapy.-Phase I/II study- - 1408PC
Second Department of Surgery, Wakayama Medical University, School of Medicine0 个研究点目标入组 10 人开始时间: 2014年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of other active malignancy 2)Pancreatic cancer infiltrated into digestive tract with serious concern of bleeding 3)Interstitial pneumonia or pulmonary fibrosis 4)Brain metastasis or symptoms of it 5)Pleural effusion, ascites, and pericardial fluid requiring drainage 6)Active infections 7)Severe nervous disorder or mental disorder 8)Severe organ disorder, equivalent to CTCAE grade3 or greater 9)History of ischemic heart disease, cerebral infarction, or thromboembolism within 12 months 10)Evidence of bleeding diathesis or severe coagulopthy, or patients with those histories 11)Need continuous medication of anticoagulant drug except aspirin 12)Pregnant females or nursing mothers who can not stop lactation after the recruitment
研究者
相似试验
招募中
1 期
A clinical study of cancer peptides vaccine therapy using URLC10, CDCA1, and KOC1-targeted peptides in the patients who had no more treatment against oral canceroral cancerJPRN-UMIN000008379Department of Oral and Maxillofacial surgery, Graduated school of medicine Kumamoto University40
招募中
1 期
A clinical study of cancer peptides vaccine therapy in the patients who have recieved surgical resection and had no residual tumor for head and neck cancerhead and neck cancerJPRN-UMIN000008380Department of Oral and Maxillofacial surgery, Graduated school of medicine Kumamoto University50
已完成
1 期
Treatment with cancer peptide vaccine cocktail derived from URLC10, KIF20A, VEGFR-1 and VEGFR-2 for the patients with advanced or recurrent esophageal cancer refractory to the standerd tharapyEsophageal cancerJPRN-UMIN000013709Wakayama Medical University40
已完成
1 期
Cancer vaccine therapy using epitope peptide from CDH3 restricted to HLA-A*2402 with gemcitabine chemotherapy in patients with unresectable advanced pancreatic cancer (Phase I study)pancreatic cancerJPRN-UMIN000005549Sapporo Medical University9
已完成
1 期
Cancer vaccine therapy using epitope peptide from KIF20A restricted to HLA-A*24 in patients with pancreatic cancer refractory to standard therapy (Phase I/II study)pancreatic cancerJPRN-UMIN000004919Chiba Tokushukai Hospital30